Nalee Kim, Radiation oncologist at Yonsei Cancer Center, shared on X/Twitter:
“We recently found out that selective high dose RT to primary breast tumor even in metastatic setting showed favorable LC outcomes.. especially for patients in < 3 lines of systemic Tx and stable extra-breast disease.!”
For details click here.
Source: Nalee Kim/Twitter